Breadth builds into July tests
Good morning. Flows are widening beyond a handful of leaders, with Industrials setting the pace while select tech and cyclicals press higher. The setup is improving, but July will test order books, pricing power, and margin durability across several groups.
Today’s market read
The backdrop is improving, but stock selection still matters.
01 Market Direction
Improving. The short-term trend is getting healthier, but not everything is confirmed.
02 Market Participation
Broadening. More stocks are joining in.
03 Strongest Sector
Industrials. Investors are showing the most interest here right now.
Midcap comms hardware climbs as orders and margins face checks
Key points
Extreme Networks guides fiscal Q4 revenue to 330 to 335 million, with shares roughly 1.7 percent below a 52-week high.
Digi International raised its fiscal 2026 outlook to 20 to 22 percent revenue growth and 25 percent annualized recurring revenue growth.
Harmonic cited 582 million dollars in backlog and lifted its Broadband revenue outlook.
Viavi’s one-year return is near 380 percent while management warns near-term visibility is limited.
Communication equipment is creeping back toward leadership, with several midcaps pushing or taking out one-year highs. Our brief on Comms hardware midcaps show life again lays out why the tape improved and where follow-through needs to show up next. The near-term test is simple. Order visibility and gross margin must confirm the move as the next print cycle approaches.
Extreme Networks rallied close to a 52-week high after a sharp three-month climb. Management’s late April update called for fiscal fourth quarter revenue of 330 to 335 million dollars and a full-year range near 1.28 billion, alongside gross margin a little above 61 percent. Delivery against those marks would support the view that the business has reset to a higher margin baseline while demand stabilizes.
IoT connectivity and broadband access pockets add support. Digi International lifted its multiyear growth outlook with a heavier subscription mix, Harmonic pointed to a 582 million dollar backlog and raised its Broadband outlook, and Viavi’s multi-bagger run collides with limited near-term visibility. Investors may want to monitor backlog conversion, recurring revenue growth, and pricing discipline as volatility remains elevated.
Flows, breadth, and weights put Industrials back in the lead
Key points
XLI is up 12.4 percent over three months alongside net creations.
Breadth and relative volume indicate accumulation across the sector.
Aerospace, machinery, and electrical equipment carry the heaviest weights.
July 1 ISM PMI and early earnings backlog updates are key tests.
Rotation is back on watch in Industrials. Industrials get flow-backed momentum details how price strength in the sector is being confirmed by fresh money moving into XLI and by healthier participation beneath the surface.
Breadth and liquidity matter here. The recent run is not just a narrow leadership cohort. Accumulation shows up in relative volume and in the sub-industry mix, with aerospace, machinery, and electrical equipment aligned with typical capital spending as cycles firm.
The next checks arrive quickly. July 1 ISM PMI will frame production and new orders, and then early earnings commentary on order books and backlog conversion can extend or stall the move. Watch whether flows stay positive and whether management teams lean into pricing and margin execution.
Biotech participation widens, but binary summer catalysts loom
Key points
Breadth and volume expanded, with industry rank near the top and about 84 percent of members positive over three months.
Tools and diagnostics show momentum as 10x Genomics and Twist hit 52-week highs on demand commentary and moves.
Platforms and specialty pharma participate, with Moderna up about 43 percent in a month and Alkermes up about 48 percent.
Near-term binary events loom, including Replimune’s early August FDA decision after a late July advisory meeting.
Risk appetite is returning beyond a handful of mega-caps. Biotech breadth builds, catalysts will decide outlines why industry rank, heavier dollar volume, and a high share of rising constituents point to early-stage expansion rather than a one-name melt-up.
Leadership is broader than usual. Tools and diagnostics are participating as 10x Genomics and Twist pressed to 52-week highs. Platform names and specialty pharma are in the mix too, with Moderna and Alkermes posting sharp one-month gains as investors reprice pipelines beyond a single franchise.
Durability will hinge on upcoming clinical and FDA events. A late July advisory committee sets up Replimune’s early August FDA decision, while summer data updates could shift expectations quickly. Monitor cash runway, enrollment updates, and any capital raising as the group navigates higher volatility.
Digi at highs balances record ARR with hardware lumpiness risk
Key points
Shares are near 52-week highs after roughly a 45 percent three-month run.
The latest quarter set records: revenue 131 million dollars, annual recurring revenue 184 million dollars, and cash from operations 41 million dollars.
Main risk is one-time hardware swings and order delays that could test the breakout.
IoT connectivity supplier Digi has been a standout in communication equipment. Digi International's highs face a demand test captures the core debate now that shares are pressing a 252-day high after a strong three-month run.
The company posted a clean set of records last quarter, including revenue of 131 million dollars, annual recurring revenue of 184 million dollars, and cash generation of 41 million dollars from operations. Management continues to lean into software and services-like subscriptions to smooth through-cycle volatility.
The risk is that hardware lumpiness or order timing interrupts the move to new highs. Watch how the mix shift shows up in gross margin, whether design wins translate to recurring revenue, and whether backlog and lead times normalize into the next report.
ON’s sharp reset refocuses the power debate on mix and margins
Key points
Shares fell 23.7 percent in the latest session and 28.6 percent over one month after a prior rally.
Q1 revenue was 1.51 billion dollars with 38.5 percent gross margin, and Q2 outlook is 1.535 to 1.635 billion dollars.
Automotive revenue was about 797 million dollars, and AI data center revenue more than doubled year over year.
Main risk is silicon carbide pricing and flat auto demand that could slow margin expansion.
A 23.7 percent one-day drop put a fast reset on a high beta power-chip story. Onsemi's 24 percent drop resets the power case walks through why the market is rechecking end-market mix, average selling prices, and factory utilization after a strong run.
Fundamentals are still moving. First quarter revenue landed at 1.51 billion dollars with non-GAAP gross margin of 38.5 percent, and second quarter guidance calls for 1.535 to 1.635 billion dollars with further margin expansion. Automotive remains the base at roughly 797 million dollars, while AI data center power demand more than doubled year over year.
The execution bar is high. Silicon carbide pricing and a flatter auto backdrop can slow the pace of margin improvement, and a recent price to earnings near 184 on recent results makes each incremental data point count. Monitor utilization, contract pricing, and how management frames mix in the next updates.
Two builders push to highs while peers pause on margins
Key points
LGI Homes is up 40.8 percent in a month as backlog jumped and margin guidance improved.
Beazer gained 19.2 percent in a month and hit a new high while incentives compressed margins.
Rates steadying aid orders, but affordability and cancellations could test margins.
Residential construction is splitting. Two builders break out as peers pause looks at why a pair of names are pressing higher while several larger peers tread water.
LGI Homes rallied 40.8 percent over the past month and 67.3 percent over three months, sitting within 5 percent of a 52-week high. Orders and backlog improved, and management nudged margin guidance higher as community mix and geography lined up with demand.
Beazer also printed a new 52-week high, with shares up 19.2 percent in a month, though incentives continue to compress margins. With mortgage rates easing off recent peaks, investors are weighing whether order strength rests on sustainable community count and mix or on incentives that could fade. Affordability and cancellations remain the swing factors.
Airlines rally into a clustered July earnings slate
Key points
Delta printed a fresh high ahead of a July 9 report and guided to low-teens Q2 revenue on flat capacity with fuel near 4.30 dollars a gallon.
United hit a new high and reports July 16, is trimming 2026 capacity by five points, and grew Q1 premium revenue 14 percent.
American set a new high ahead of a July 23 report with Q2 revenue up 13.5 to 16.5 percent and fuel assumed near 4.00 dollars.
Southwest is up 24.7 percent in a month and reports July 22, guiding to Q2 RASM growth of 16.5 to 18.5 percent with capacity flat to up 1 percent.
Carriers pushed to fresh highs into a busy July earnings window. Airlines rally into July earnings tests frames the debate around demand, capacity discipline, and how much of spring’s fuel spike can be recaptured in pricing.
Delta and United set the early pace. Delta reports July 9 after guiding to low-teens June quarter revenue growth on flat capacity with fuel near 4.30 dollars a gallon. United reports July 16 and is pulling back its 2026 capacity plan by about five points while premium revenue grew 14 percent in the first quarter.
American and Southwest follow later in the month. American sees second quarter revenue growth of 13.5 to 16.5 percent with assumed fuel near 4.00 dollars, and Southwest is up 24.7 percent in a month while guiding to strong unit revenue on flat to slightly higher capacity. Unit revenue and unit cost commentary will set the tone for the rest of the year.
Next up are early July macro reads and the first wave of earnings. Watch ISM PMI on July 1, then order books, backlog conversion, pricing, and margin cadence across Industrials, comms hardware, biotech pipelines, homebuilders, semis, and the airlines. Stay patient on confirmation and let the data do the nudging.